In patients with MI/PAD and no prior stroke or transient ischemic attack , vorapaxar reduced first ischemic stroke ( hazard ratio [ HR ] : 0.57 , 95 % confidence interval [ CI ] : 0.43 to 0.75 ; p < 0.001 ) .